A VISION TO BE THE BEST      

A- A A+

A Vision to be the Best

As the largest group of Retina specialists in the Greater Kansas City, Topeka, Sedalia and surrounding areas we offer multiple professional offices to serve you.  Each of our offices are staffed and equipped to provide the highest level of health care service and access in a comfortable environment.

David S. Dyer, M.D., F.A.C.S.

Dr. Dyer CURRICULUM VITAE

NAME

  • David S. Dyer, M.D.

BIRTHDATE

  • April 10, 1960; Danville, New Jersey

WORK HISTORY

May 1, 1999 -PRESENT:

  • Retina Associates, P.A.  
    Santa Fe Medical Building
    9301 W 74th Street
    Suite 210
    Shawnee Mission, KS 66204
  • Retina Associates. P.A.
    10100 N Ambassador Drive
    Suite 100
    Kansas City, MO 64153
  • Retina Associates, P.A.
    6001 SW 6th Avenue
    Suite 300
    Topeka, KS 66615
  • Retina Associates, P.A.
    3700 W 10th Street
    Suite 101
    Sedalia, MO 65301
  • Retina Associates, P.A.
    100 NE Missouri Road
    Suite 203
    Lee's Summit, MO 64086

January 1, 1997- April 30, 1999:

  • Mid-America Retina Consultants, P. A.
    4321 Washington Street
    Suite 5000
    Kansas City, MO 64111

July 7, 1994 - March 15, 1997

  • Illinois Retina Associates, S.C.
    71 W. 156th Street
    Suite 400
    Harvey, IL 60426

EDUCATION

  • PREPARATORY: Annandale High School, Annandale, Virginia
  • UNDERGRADUATE: George Mason University, Fairfax Virginia
  • MEDICAL: University of Kansas School of Medicine, Kansas City, Kansas
  • INTERNSHIP: Medicine - University of Kansas Medical Center, Kansas City, Kansas, Department of Internal Medicine (April 1, 1989 - June 30, 1990)
  • RESIDENCY: Ophthalmology - Medical University of South Carolina, Storm Eye Institute, Charleston, South Carolina (July 1, 1990 - June 30, 1993)
  • FELLOWSHIP: Medical Retina - The Wilmer Ophthalmological Institute, The Johns Hopkins University, Baltimore, Maryland (July 7, 1993 - June 30,1994) Fellowship Director: Andrew P. Schachat, M.D.
  • FELLOWSHIP: Surgical Retina - Rush-Presbyterian Hospital/Ingalls Memorial Hospital, Illinois Retina Associates, Harvey, Illinois (July 7, 1994 - June 30, 1995) Fellowship Director: Kirk H. Packo, M.D.

DEGREES EARNED

  • B.S. - January 1984
  • M.D. - May 1989

LICENSURE

  • Diplomat American Board of Ophthalmology
  • Kansas State License
  • Missouri State License
  • Illinois State License
  • Maryland State License
  • South Carolina State License

MEMBERSHIPS

  • American Medical Association
  • American Academy of Ophthalmology
  • Johnson County Medical Society
  • Kansas Medical Society
  • Metropolitan Medical Society of Greater Kansas City
  • Kansas State Ophthalmological Society
  • Kansas City Society of Ophthalmology and Otolaryngology
  • Missouri State Medical Association
  • Missouri Society of Eye Physicians & Surgeons
  • F.R.A.M.E.
  • Chicago Medical Society
  • Wilmer Residents Associate
  • ARVO

ACADEMIC APPOINTMENT

  • Assistant Professor, Rush Medical College, Rush-Presbyterian-St. Luke’s Medical Center, Chicago, Illinois (July 7, 1995 - December 31, 1996)

PUBLICATIONS

  • A Kiri, DS Dyer, NM Bressler, SB Bressler, AP Schachat: “Detection of Diabetic Macular Edema: Nidek 3Dx Stereophotography Compared with Fundus Biomicroscopy.” American Journal of Ophthalmology November 1996
  • Gurecki PJ, Holden KR, Sahn EE, Dyer DS, Cure JR: Developmental Neural Abnormalities and Seizures in Epidermal Nevus Syndrome.” Developmental Medicine and Child Neurology 1996;38:716-723
  • Dyer DS, Brant AM, Schachat AP, Bressler SB, Bressler NM: “Angiographic Features and Outcome of Questionable Recurrent Choroidal Neovascularization.” American Journal of Ophthalmology 1995;120:497-505
  • Dyer DS: “Scleral Patch Graft for Closure of Sclerotomies.” Vitreoretinal Surgery and Technology 1995;7(3):1-4
  • Dyer DS, Bressler NM: “Laser Wavelength-It’s Role in the Treatment of Vitreoretinal Diseases.” Current Opinion in Ophthalmology 1994;5:III:35-43
  • Dyer DS, Small KW, Wilson ME, Pai GS: “Alstrom Syndrome: A Case Misdiagnosed as Bardet-Biedl Syndrome.” Journal of Pediatric Ophthalmology and Strabismus 1994;31:272-274

PRESENTATIONS

  • David Dyer, M.D.: “Look Deep Into My Eyes.” Greater Kansas City ASORN, Kansas City, Missouri (March 27, 2010)
  • David Dyer, M.D.: “Integrated Pressure Infusion and IOP Control.” Constellation Vision System (November 6, 2008)
  • DS Dyer, GM Fox, BA Cooper: “Outcomes and Complications of 25-gauge Vitrectomies.” Masters of the ASRS, Nassau, Bahamas (March 13-16, 2005)
  • Dyer DS: “Babes in Arms - Retinopathy of Prematurity.” Greater Kansas City ASORN, Kansas City, Missouri (February 28, 2004)
  • Dyer DS: “Diabetic Retinopathy and Cataract Surgery.” The Art of Diabetic Care Conference, Kansas City, Missouri (September 20, 1997)
  • A Kiri, SR O’Connell, DS Dyer, NM Bressler, SB Bressler, AP Schachat, D Finkelstein: “Comparison of Stereo Photography by Nidek 3Dx Camera with Zeiss Camera in Detecting Diabetic Macular Edema.” ARVO Annual Meeting, Fort Lauderdale, Florida (May 11-16, 1997)
  • DS Dyer, A Kiri, SR O’Connell, NM Bressler, SB Bressler, AP Schachat: “Intra- and Inter-Observer Agreement in Detecting Diabetic Macular Edema by Grading Nidex 3DX Stereo Photographs.” ARVO Annual Meeting, Fort Lauderdale, Florida (May 11-16, 1997)
  • SR O’Connell, A Kiri, DS Dyer, CJ Hiner, NM Bressler, SB Bressler, AP Schachat: “The Influence of Training Ophthalmologist to Grade Fundus Stereo Photographs for Detecting Diabetic Macular Edema.” ARVO Annual Meeting, Fort Lauderdale, Florida (May 11-16, 1997)
  • DS Dyer: “Diabetes I - Medical Consideration, ETDRS, DCCT and Eurodiab IDDM Trial Results, Nonproliferative Diabetic Retinopathy.” The 6th Annual Rush Medical College Ophthalmology Clinical Review Course, Chicago, Illinois (April 13, 1997)
  • Dyer DS: “Current Concepts and Indications for Vitreo-Retinal Surgery.” Copley-Mercy Consortium, Aurora, Illinois (November 5, 1996)
  • DH Orth, DS Dyer: “Foveal Sparing Photocoagulation for Exudative Age Related Macular Degeneration.” The First Jerusalem International Congress On Retinal and Vitreous Diseases, Jerusalem, Israel (June 30 - July 4, 1996)
  • DS Dyer: “Disorders of the Posterior Pole.” Diagnostic Pharmaceutical Agent Training and Certification Course, The National Eye Research Foundation, Oak Lawn, Illinois (March 23-24, 1996)
  • DS Dyer: “Subretinal Surgery: Advances in Indications and Techniques.” The 5th Annual Rush Medical College Ophthalmology Clinical Review Course, Chicago, Illinois (March 24, 1996)
  • DS Dyer: “Anatomy and Pathophysiology of Age-Related Macular Degeneration.” The 5th Annual Rush Medical College Ophthalmology Clinical Review Course, Chicago, Illinois (March 22, 1996)
  • DS Dyer: “Diabetic Retinopathy.” The Lions of Illinois Foundation Executive Meeting, Peoria, Illinois (February 16, 1996)
  • DS Dyer: “Techniques of Silicone Oil Removal.” Silicone Oil Surgery: A Multi-Centered Course, Chicago, Illinois (October 14, 1995)
  • DS Dyer, KH Packo, R Shetty: “YAG Posterior Hyaloidotomy for Subhyaloid Hemorrhage.” The Retina Society, Twenty-Sixth Scientific Session, London, England (September 6-10, 1995)
  • DS Dyer, LM Jampol, KH Packo: “Evaluation of Computerized Overlay Techniques in Digital Angiography.” ARVO Annual Meeting, Fort Lauderdale, Florida (May 14-19, 1995)
  • Kiri, DS Dyer, NM Bressler, SB Bressler, AP Schachat: “Comparison of Nidek 3Dx Camera with Fundus Biomicroscopy in the Detection of Diabetic Edema.” ARVO Annual Meeting, Fort Lauderdale, Florida (May 14-19, 1995)
  • A Kiri, DS Dyer, NM Bressler, SB Bressler, AP Schachat: “Comparison of Nidek 3Dx Camera with Fundus Biomicroscopy in the Detection of Diabetic Edema.” The 54th Clinical Meeting of the Wilmer Residents Association (April 27-29, 1995)
  • Dyer DS: “Diabetic Retinopathy: Review of Diabetes Mellitus, DCCT Trial and the ETDRS Trial.” The 4th Annual Rush Medical College Ophthalmology Clinical Review Course, Chicago, Illinois (March 12, 1995)
  • Dyer DS, Brant AM, Schachat AP, Bressler SB, Bressler NM: “Patterns of Questionable Recurrent Choroidal Neovascularization.” ARVO Annual Meeting, Sarasota, Florida (May 1-5, 1994)
  • Brant AM, Dyer DS, Schachat AP, Bressler SB, Bressler NM: “Subtle Clinical Signs of Recurrent Choroidal Neovascularization.” ARVO Annual Meeting, Sarasota, Florida (May 1-5, 1994)
  • Dyer DS, Brant AM, Schachat AP, Bressler SB, Bressler NM: “Patterns of Questionable Recurrent Choroidal Neovascularization.” 53rd Clinical Meeting of the Wilmer Residents Association (April 21-23, 1994)
  • Brant AM, Dyer DS, Schachat AP, Bressler SB, Bressler NM: “Subtle Clinical Signs of Recurrent Choroidal Neovascularization.” 53rd Clinical Meeting of the Wilmer Residents Association (April 21-23, 1994)
  • Dyer DS, Palesch YY, King LP: “Ocular Hypertension Following Pars Plana Vitrectomy.” Poster at the 1993 American Academy of Ophthalmology Annual Meeting, Chicago, Illinois (November 14-18, 1993)
  • Dyer DS, King LP: “Ocular Hypertension Following Pars Plana Vitrectomy.” Pediatric and Strabismus Update, Kiawah Island, South Carolina (June 1-3, 1993)
  • Dyer DS, King LP: “Risk Factors and Treatment of Postoperative Intraocular Pressure Spike Following Vitrectomy.” ARVO Annual Meeting, Sarasota, Florida (May 2-7, 1993)
  • Dyer DS: “Infection Control in the Office.” 1992 Corneal and External Disease Update, Charleston, South Carolina (May 22-24, 1992)
  • Dyer DS: “Post-op Pressure Rise in Intravitreal Gas Injection.” 1992 Corneal and External Disease Update, Charleston, South Carolina (May 22-24, 1992)
  • Dyer DS, Small KW, Wilson ME, Pai GS: “Alstrom Syndrome: A Case Misdiagnosed as Bardet-Biedl Syndrome.” The 14th Annual Ophthalmic Genetics Study Club, Anaheim, California (October 12, 1991)
  • Dyer DS: “Indications and Usage of Low Dose Fluorescein Angiograms.” Glaucoma Diagnostic and Therapeutic Update, Kiawah Island, South Carolina (April 12-14, 1991)

ARTICLES IN PREPARATION

  • Brant AM, Dyer DS, Schachat AP, Bressler SB, Bressler NM: “Subtle Signs of Questionable Recurrent Choroidal Neovascularization.” (Submitted to Retina)
  • Dyer DS, Packo KH: “Retinotomies and Retinectomies.” (To be published in Ophthalmic Practice)

CLINICAL RESEARCH

  • Alcon: C-01-99, Sub-Investigator, Posterior Juxtascleral Injection of Anecortave Acetate versus Sham for inhibition of CNV in Non-Exudative AMD, 08/2003 – 8/2005.
  • Alcon: C-05-62, Principal Investigator, Clinical Evaluation of the Safety and Efficacy of Preservative-Free Triamcinolone Acetonide Sterile Suspension for Visualization During Vitreoretinal Surgery, 8-9/2007.
  • Alcon: C-02-60, Sub-Investigator, Anecortave Acetate Risk Reduction Trial for patients with Non-Neovascular AMD, 03/2004-08/2008.
  • Alcon: C-04-59, Sub-Investigator, Interval Dose Evaluation of Anecortave Acetate for those with Neovascular AMD, 01/2005 – 02/2008.
  • Allergan: 206207-008, Sub-Investigator, Posurdex Retinal Vein Occlusion, 01/2005 – 02/2009.
  • Allergan: 206207-010, Sub-Investigator, Posurdex Diabetic Macular Edema, 03/2005 – present.
  • DRCR: Intravitreal Triamcinolone study B, Principle Investigator, Focal laser treatment versus Intravitreal Injection Triamcinolone for treatment of Diabetic Macular Edema, 06/2005 – 10/2006.
  • Eyetech/OSI: EOP1023, Principle Investigator, Intravitreal Injection of Pegaptanib Sodium for Neovascular AMD, 05/2006 – 07/2008.
  • Eyetech IST: Principle Investigator, Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease (PRESERVE), Sub-Investigator, Intravitreal Injections of Pegaptanib every 4 weeks compared to every 6 weeks for the treatment of Diabetic Macular Edema, 05/2009.
  • Eyetech: EOP1024, Investigator, Intravitreal Injection of Pegaptanib Sodium administered every 6 weeks for 48 weeks for Subfoveal Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, or Retinal Vein Occlusion to determine the adverse effects on the corneal endothelium, 04/2010 – present.
  • Genaera: 301, Principle Investigator, Squalamine Lactate IV infusion for treatment of Neovascular AMD, 09/2005 – 09/2008.
  • Genentech: FVF4165g, Sub-Investigator, Intravitreal Injection of Ranibizumab for Branch Retinal Vein Occlusion, 02/2008 – 01/2010.
  • Genentech: FVF4166g, Sub-Investigator, Intravitreal Injection of Ranibizumab for Central Retinal Vein Occlusion, 02/2008 – 01/2010.
  • Genentech: FVF4168g, Sub-Investigator, Intravitreal Injection of Ranibizumab for Diabetic Macular Edema, 08/2007 – present.
  • Genentech: FVF4295, Sub-Investigator, Evaluation of Ranibizumab on ease of procedure and complications in PDR requiring vitrectomy, 09/2007 – present.
  • Genentech: FVF3426g, Sub-Investigator, Intravitreal Injections of Ranibizumab for Branch Retinal Vein Occlusion and Central Retinal Vein Occlusion for subjects who have completed a Genentech Sponsored Ranibizumab Study, 02/2009 – 10/2010.
  • Genentech: FVF4579g, Sub-Investigator, Intravitreal Injection of either 0.5mg or 2.0mg Ranibizumab administered monthly or on an as needed basis for subjects with Subfoveal Neovascular Age-Related Macular Degeneration, 06/2009 – present.
  • Eli Lily: B7A-MC-MBCM, Sub-Investigator, Ruboxistaurin Mesylate for patients with Diabetic Retinopathy, 01/2003– 04/2006.
  • Eli Lily: B7A-MC-MBDV, Sub-Investigator, Open-Label treatment for Patients completing Study B7A-MC-MBCM, 02/2006-11/2008.
  • Novartis: Principle Investigator, Insight CNV Registry, 11/2005 – 08/2006.
  • Ophthotech: OPH3000, Principle Investigator, Intravitreal Injection of Volociximab in combination with Ranibizumab for Neovascular Age-Related Macular Degeneration, 10/2008 – 12/2009.
  • Ophthotech: OPH1001, Principle Investigator, Intravitreal Injection of E10030 (Anti-PDGF Peglayted Aptamer) in combination with Ranibizumab for Neovascular Age-Related Macular Degeneration, 05/2010 – present.
  • Principal Investigator, Submacular Surgery Trials. 1998 - 1999
  • Principal Investigator, An Open Label Study of the Safety and Efficacy of Intravitreal ISIS 2922 in Acquired Immune Deficiency Syndrome (AIDS) Patients with Cytomegalovirus Retinitis. (Protocol ISIS 2922-CS7) 1997
  • Clinical Investigator, ASPEN Diabetic Retinopathy Substudy. 1997
  • Clinical Investigator, Age-Related Eye Disease Study (AREDS). (NIH Grant #NO1-#EY02124) 1995
  • Co-Investigator, Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity. 1995
  • Clinical Investigator, Silicone Oil Study. 1995
  • Clinical Investigator, Perfluorone Study. 1995

A Vision to be the Best

Retina Associates, PA

9301 W 74th St Ste 210
Shawnee Mission, KS 66204

 

Map of our location

Email Us

From (E-mail Address):
Hello, my name is I am interested in scheduling an appointment with your Retina Associates, P.A. and would like to receive information about
Please call me at at your earliest convenience. Thank You!